Prelude Therapeutics Incorporated Common Stock
NASDAQ · PRLD
Fundamentals
Market cap
$366.37M
Price / Earnings ratio
-5.2x
Price / Sales ratio
24.1x
Price / Book ratio
6.7x
Return on assets
-0.7%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


